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Abstract: Capsaicin possesses cytotoxic/anticancer activity and shares some common structural features, including a benzene ring and a
long hydrophobic carbon tail, with the histone deacetylase (HDAC) inhibitors trichostatin A and suberoylanilide hydroxamic acid. The
aims of this study were to investigate HDAC inhibitory and cytotoxic activities of a synthetic derivative of capsaicin, hydroxycapsaicin
(6-hydroxy-N-(4-hydroxy-3-methoxybenzyl)-8-methylnonenamide), in colon cancer cell lines. Hydroxycapsaicin inhibited HDAC
activity in vitro (IC50 = 72 µM) much more effectively than the prototype capsaicin (IC50 > 13.1 mM) and also exhibited HDAC
inhibitory activity in human cells (HeLa cells). MTT assay demonstrated that hydroxycapsaicin was less toxic than capsaicin against
both cancer and noncancer cells; however, hydroxycapsaicin, with greater HDAC inhibitory activity, was more effective than capsaicin at
inducing apoptosis in colon cancer cell lines, especially in HCT116 cells. Hydroxycapsaicin appeared to induce less apoptotic cell death
than capsaicin in Vero cells. Moreover, only hydroxycapsaicin induced S-phase cell-cycle arrest in both HT29 and HCT116 cells. The
current study demonstrates that hydroxycapsaicin can act as a novel HDAC inhibitor, which would lead to a promising strategy for the
development of safe and effective chemotherapeutic drugs from the abundant natural capsaicin of chili pepper.
Key words: Capsaicin, apoptosis, cell-cycle arrest, cytotoxicity, HDAC inhibitor, colon cancer

1. Introduction
Chili peppers are commonly used as an ingredient in many
cuisines and are eaten by many people around the world.
Capsaicinoids, including capsaicin, dihydrocapsaicin,
nordihydrocapsaicin,
homodihydrocapsaicin,
and
homocapsaicin, are the major active components of chili
peppers, which not only add spice to the food but also
possess potential anticancer (Surh, 2002; Zhang et al.,
2003; Oh and Lim, 2009; Choi et al., 2010a; Ghosh and
Basu, 2010; Thoennissen et al., 2010; Yang et al., 2010; Jin et
al., 2014), antiinflammatory (Lee et al., 2010), antioxidant
(Nascimento et al., 2014), antiobesity (Reinbach et al.,
2009; Saito and Yoneshiro, 2013), and analgesic (Knotkova
et al., 2008) activities. Capsaicin, the most abundant
capsaicinoid found in chili peppers, has been shown to
bind vanilloid receptors on the cell membranes of various
cell types (Jordt and Julius, 2002). Vanilloid receptors
are a nonselective cation channel gated by noxious heat,
vanilloids, and extracellular protons and are involved in
the etiology of inflammatory pain, such as inflammatory
* Correspondence: sthanaset@kku.ac.th
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bowel disease, bladder inflammation, and cancer pain
(Messeguer et al., 2006). The role of vanilloid receptors in
the cytotoxicity of capsaicin is not fully understood, but is
likely that different cell lines respond in unique manners
to stimulation of this receptor by capsaicin/ligand binding
(Reilly et al., 2003). Although the anticancer activity
of capsaicin has been extensively documented, there is
evidence that some capsaicin metabolites may cause DNA
damage, leading to carcinogenesis (Baez et al., 2010). Lui et
al. (2012) demonstrated that capsaicin at low concentrations
upregulated the expression of tumor-associated NADH
oxidase in the human colon carcinoma cell line HCT116,
in association with enhanced cell proliferation and
migration. Furthermore, epidemiological data showed
that people who consume chili peppers in large amounts
have a higher risk of gastric cancer (Lopez-Carillo et al.,
1994). Therefore, capsaicin has been considered a doubleedged sword with both carcinopreventive and carcinogenic
properties. Nonetheless, capsaicin is not mentioned in the
current list of natural chemopreventive agents (Mehta,
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2014). Moreover, its high concentration requirement is
a potential limitation for the use of capsaicin in cancer
therapy (Luo et al., 2011). Accordingly, modification
of capsaicin’s chemical structure may overcome the
drawbacks of this naturally available compound.
Recently, inhibition of histone deacetylase (HDAC)
activity has been considered a promising mechanism for
cancer therapy, especially for combination chemotherapy
(Carew et al., 2008; Bots and Johnstone, 2009; Ma et al.,
2009; Mark and Xu, 2009). In the last 15 years, a number of
HDAC inhibitors from natural sources and from chemical
libraries have been studied, particularly their anticancer
activity or toxicity on various cancer cell lines (Mark and
Xu, 2009). However, there is a continuous need to develop
new HDAC inhibitors with better pharmacological
efficacy and novel modes of action in comparison
to known HDAC inhibitors. Based on the structural
similarity of capsaicin to the potent HDAC inhibitors
trichostatin A (TSA) and suberoylanilide hydroxamic acid
(SAHA), several capsaicin derivatives were synthesized
(Kumboonma, 2010) in order to explore potential
therapeutic drugs from capsaicin-based compounds. In
this study, the HDAC inhibitory activity of a capsaicin
derivative, hydroxycapsaicin (6-hydroxy-N-(4-hydroxy3-methoxybenzyl)-8-methylnonenamide), was evaluated
comparatively with a prototype capsaicin. The cytotoxic
effects of hydroxycapsaicin on growth, apoptosis, and cellcycle progression of human colon cancer cell lines were
investigated in order to validate its anticancer potency,
which would lead to a future study on its possible use as
an anticancer agent.
2. Materials and methods
2.1. Cell lines and reagents
HCT116 and HT29 cells (human colon cancer cells)
were obtained from Dr Osamu Tetsu (University of
California, San Francisco, USA) and Dr Pornticha Picha
(National Cancer Institute, Thailand), respectively. Both
cell lines possess capsaicin/vanilloid receptors on their cell
membrane (Bromberg et al., 2013; de Jong et al., 2014). Vero
cells (African green monkey kidney cells) obtained from
Dr Sahapat Barusrux (Khon Kaen University, Thailand)
were chosen for this study as they lack a capsaicin receptor
(Creppy et al., 2000). Capsaicin was purchased from
Sigma-Aldrich Corporation (USA). Hydroxycapsaicin was
synthesized as previously described (Kumboonma, 2010).
2.2. Cell culture
HCT116, HT29, and Vero cells were maintained in RPMI1640 supplemented with 10% fetal bovine serum, 100 U/
mL penicillin, and 100 µg/mL streptomycin (Gibco-BRL)
at 37 °C in a humidified incubator with an atmosphere of
95% air and 5% CO2.

2.3. Assessment of HDAC inhibition in vitro
Inhibition of HDAC activity in vitro was assessed using the
Fluor-de-Lys HDAC activity assay kit (Biomol, Enzo Life
Sciences International, Inc., USA). HeLa nuclear extract
provided with the kit was used as a source of HDAC
enzymes for in vitro study. The spectra Max Gemini XPS
microplate spectrofluorometer (Molecular Devices, USA)
was used to measure fluorescence signal with excitation at
360 nm and emission at 460 nm. A decrease in fluorescence
signal indicated an inhibition of HDAC activity.
2.4. Assessment of HDAC inhibition in human cells
HeLa cells with high levels of HDAC expression were
chosen as a cellular model for evaluation of HDAC
inhibition in human cells. Cells (1 × 106 cells) were seeded
into a 4.5-cm dish. After incubation for 24 h, cells were
treated with hydroxycapsaicin (50–200 µg/mL) for 6 h.
Cells treated with a pan HDAC inhibitor TSA (5 nM)
and DMSO (0.37%) were used as positive and negative
controls, respectively. Histone proteins were extracted
from treated cells as previously described (Senawong
et al., 2013). Acetylated histone H4 in HeLa cells was
determined by acid-urea-Triton (AUT) polyacrylamide
gel electrophoresis.
2.5. AUT X-100 polyacrylamide gel electrophoresis
To evaluate HDAC inhibition in human cells, AUT gel
electrophoresis was used to measure hyperacetylation of
histone H4 as described previously (Senawong et al., 2013).
AUT gels were stained using the PageSilver Silver Staining
Kit (Fermentas, Canada). The abundance of triacetylated
histone H4 was quantified with Quantity One software
(Bio-Rad, USA).
2.6. MTT assay
Determination of antiproliferative activity or cytotoxicity
of hydroxycapsaicin and capsaicin was performed using
MTT assay as described previously (Senawong et al., 2013)
with some modifications. In brief, HT29, HCT116, and
Vero cells were treated with hydroxycapsaicin and capsaicin
at varied concentrations (25, 50, 100, 200, 400 µg/mL),
and incubated for 24, 48, and 72 h. After replacing culture
medium, the cells were treated with 10 µL of MTT for 2 h
at 37 °C. The formazan dye was dissolved with DMSO and
determined by measuring the absorbance at 550 nm, using
the absorbance at 655 nm as a reference wavelength with
a microplate reader (Bio-Rad Laboratories, USA). The
production of formazan was proportional to the number
of viable cells.
2.7. Analysis of apoptosis by flow cytometry
Apoptosis analysis was performed using Vybrant Apoptosis
Assay Kit #2 (Molecular Probes, Invitrogen Corporation,
USA) according to the manufacturer’s instructions. HT29,
HCT116, and Vero cells (1 × 106 cells) were seeded into
a 4.5-cm dish and treated with various concentrations of
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hydroxycapsaicin or capsaicin (50, 100, 200 µg/mL) for 24
h. Cells were then harvested by trypsinization, washed with
PBS, and resuspended in ice-cold annexin-binding buffer
added to Alexa Fluor 488 annexin V and propidium iodide
(PI) solutions. Cells were stained in the dark for 15 min at
room temperature and analyzed by flow cytometry using
a BD FACSCantoII Flow Cytometer (Becton Dickinson,
USA).
2.8. Analysis of cell-cycle arrest by flow cytometry
Cell-cycle phase distribution was determined as previously
described (Poolman and Brooks, 1998). Briefly, HT29,
HCT116, and Vero cells were seeded into a 5.5-cm dish
(1 × 106 cells/dish), incubated for 24 h, and treated with
hydroxycapsaicin and capsaicin (50, 100, and 200 µg/
mL) or vehicle (DMSO, 0.37%) for 24 h. Cells were then
harvested by trypsinization and washed once with PBS.
Cells were fixed in 1 mL of ice-cold 70% ethanol for 30 min
at 4 °C and then centrifuged at 340 × g for 5 min. The pellet
was resuspended in 0.5 mL of PBS and subsequently added
to 10 µL of PI staining solution (50 µg/mL of PI in PBS)
and 0.1 mg/mL of RNase. After incubation at 37 °C for 40
min, the stained cells were subjected to flow cytometric
analysis using a BD FACSCantoII flow cytometer (Becton
Dickinson, Canada).
2.9. Statistical analysis
All quantitative data are expressed as means ± standard
deviation (SD) calculated from 3 replicate experiments.
All the statistical analysis was carried out by SPSS 11.5
for Windows (SPSS Corporation, USA). The significant
difference between 2 groups was assessed by one-way
ANOVA with Duncan’s post hoc test. A probability value
of P < 0.05 was set for statistical difference.

3. Results
3.1. Hydroxycapsaicin exhibited greater HDAC
inhibitory activity than the prototype capsaicin in vitro
Capsaicin shares some structural characteristics, including
a benzene ring and a long hydrophobic carbon tail, with pan
HDAC inhibitors TSA and SAHA. We first investigated the
in vitro HDAC inhibitory activity of capsaicin using HeLa
nuclear extract as a source of HDAC enzymes; however,
capsaicin showed little effect on HDAC inhibition in vitro,
with an IC50 value of >4001 µg/mL (>13,000 µM) (Table
1). Therefore, hydroxycapsaicin was synthesized by adding
a hydroxyl group to a position near the end of a long
hydrophobic carbon tail in order to mimic the chemical
structure of SAHA and TSA (Kumboonma, 2010). As
expected, hydroxycapsaicin exhibited HDAC inhibitory
activity in vitro with an IC50 value of 23.29 µg/mL (72
µM) (Table 1), indicating a greater HDAC inhibition
potency than the prototype capsaicin. Nonetheless, HDAC
inhibitory activity of hydroxycapsaicin was much less
potent compared with that of the pan HDAC inhibitor,
TSA (IC50 = 0.049 µM).
3.2. HDAC inhibitory activity of hydroxycapsaicin in
HeLa cells
Based on our findings from the in vitro study, we next
investigated the HDAC inhibitory activity of hydroxycapsaicin
in a cellular context. In general, HDAC inhibition causes
accumulation of acetylated histone molecules. Therefore,
hyperacetylation of histone H4 in HeLa cells was
investigated upon treatment with hydroxycapsaicin. HeLa
cells were chosen as a model system because they express
many HDAC isozymes, including HDAC 1, 2, 3, 4, and 8
(Hassig et al., 1998; Hu et al., 2000; Fischle et al., 2002; Khan

Table 1. In vitro HDAC inhibitory activities of hydroxycapsaicin and capsaicin.
Compounds

Molecular weight
(g/mol)

TSAb

Chemical structure

IC50 valuesa
µM

µg/mL

302.37

0.049

0.015

Capsaicin

305.42

>13,100

>4001

Hydroxycapsaicin

323.43

72

23.29

IC50 values represent concentrations of the indicated compounds that inhibit 50% of HDAC activity.
TSA (trichostatin A) is a potent HDAC inhibitor.

a

b
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et al., 2008). HDAC inhibition in HeLa cells was analyzed by
AUT gel electrophoresis, whereby the cellular core histone
H4 with different levels of acetylation can be separated. The
profiles of histone H4 extracted from hydroxycapsaicin-,
TSA-, or DMSO-treated HeLa cells are given in Figure 1.
The addition of hydroxycapsaicin to cell cultures resulted in
Hydroxycapsaicin
TSA

C

DMSO

100

50

200

µg/mL
H
H2B
4
3
2
1
0

Fold change
(triacetylated H4)

1.5
*

*

*

50

100

200

H4

1.0

0.5

0.0
C

DMSO

µg/mL

Hydroxycapsaicin

Figure 1. HDAC inhibitory activity of hydroxycapsaicin in
human cells (HeLa cells). After 6 h of treatment, the level of
acetylated histone H4 was determined by AUT gel electrophoresis
as described in Section 2.5. Control (C) and DMSO represent
the levels of acetylated histone H4 in untreated and solvent
control treated cells, respectively. The TSA treatment was used
as a positive control. The degree of histone acetylation of histone
H4 is indicated as follows: 0, nonacetylated; 1, monoacetylated;
2, diacetylated; 3, triacetylated; and 4, tetraacetylated. The
data shown are representative of 2 independent experiments
performed in duplicate. Bar graph shows fold change of
triacetylated histone H4. Level of triacetylated histone H4 from
untreated cells (C) was normalized to a value of 1.0. Asterisks
indicate statistical significance (P < 0.05) compared with the
solvent control treatment (DMSO).

the accumulation of hyperacetylated histone H4 molecules,
specifically triacetylated H4 molecules, at the concentration
of 200 µg/mL (618.37 µM). However, HDAC inhibition of
hydroxycapsaicin in HeLa cells was less effective compared
to that of a positive control TSA (5 nM), a very potent HDAC
inhibitor. These results suggest that hydroxycapsaicin enters
the cells and inhibits HDAC enzymes in the nucleus.
3.3. Effect of hydroxycapsaicin on proliferation of human
colon cancer cell lines
Toxicity or antiproliferative activity of hydroxycapsaicin
against human colon cancer cell lines (HCT116 and HT29
cells) and a cell line lacking capsaicin receptors (Vero cells) was
investigated comparatively with capsaicin by MTT method,
a tetrazolium-based colorimetric cell viability assay. As
expected, both capsaicin and hydroxycapsaicin inhibited the
growth of HT29, HCT116, and Vero cells in a concentrationand time-dependent manner (Table 2). Interestingly, both
capsaicin and hydroxycapsaicin were slightly more toxic to
Vero cells than to the colon cancer cell lines. Based on IC50
values at 24-, 48- and 72-h exposures, capsaicin was about
twice as toxic as hydroxycapsaicin to all cell lines tested. The
effect of hydroxycapsaicin on the growth of both HT29 and
HCT116 cells was not significantly different.
3.4. Effect of hydroxycapsaicin on apoptosis induction in
human colon cancer cell lines
Capsaicin inhibited the growth of several cancer cells via
induction of both apoptosis (Lin et al., 2013; Jin et al., 2014)
and autophagy (Oh and Lim, 2009; Choi et al., 2010b).
However, cancer cell death via apoptosis induction is more
preferable in cancer therapy due to the cytoprotective role
of autophagy (Vazquez-Martin et al., 2009; Dalby et al.,
2010). To confirm that induction of apoptosis underlies
the antiproliferative activity of hydroxycapsaicin, its
capacity to induce apoptosis in colon cancer cell lines was
examined. Colon cancer cell lines and Vero cells were treated
comparatively with different concentrations (50, 100, 150 mg/
mL) of both hydroxycapsaicin and capsaicin for 24 h and then
stained with Alexa Fluor 488-annexin V and PI, followed by

Table 2. Antiproliferative activities of hydroxycapsaicin and capsaicin against colon cancer cell lines.
IC50 valuesa (mean ± SD; n = 3; µg/mL)
Compounds

Molecular
weight (Da)

HT29 cells

Vero cellsb

HCT116 cells

24 h

48 h

72 h

24 h

48 h

72 h

24 h

48 h

72 h

Capsaicin

305.42

68.60
± 2.86

52.98
± 1.88

51.19
± 1.26

70.51
± 1.44

67.13
± 8.36

64.23
± 1.26

57.15
± 3.22

54.60
± 2.17

53.28
± 2.79

Hydroxycapsaicin

323.43

107.88
± 5.17

103.37
± 0.13

95.44
± 3.95

134.36
± 10.48

118.93
± 0.55

114.26
± 0.29

129.58
± 2.04

127.46
±1.54

116.27
± 0.66

IC50 values represent concentrations of the indicated compounds that inhibit 50% of cell proliferation.

a

A cell line lacking capsaicin receptors.

b
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quantitative flow cytometric analysis. Surprisingly, capsaicin

cells than in HCT116 and HT29 cells (Figure 2). In contrast,

induced much greater levels of apoptotic cell death in Vero

hydroxycapsaicin induced minimal apoptotic cell death

A

Solvent control
1.5%

Camptothecin 10 g/mL

0.1%

0.0%

Vero cells

0.0%

98.3 %

0.1%

Capsaicin 50 g/mL
1.5%

98.3 %

0.1%

0.1%

84.6 %

16.0%

Capsaicin 100 g/mL
17.5%

35.0%

20.1%

26.7%

Capsaicin 200 g/mL
9.6%

17.4%

17.4%

55.2%

Hydroxycapsaicin 50 g/mL Hydroxycapsaicin 100 g/mL Hydroxycapsaicin 200 g/mL

5.0%

0.1%

2.3%

0.3%

2.1%

0.6%

Number of apoptic cells (%)

Propidium iodide PI

100

80
70
60
50
40
30
20
10
0

94.8%

Camptothecin 7 g/mL

0.3%

2.0%

97.4 %

Capsaicin 50 g/mL
0.7%

95.4 %

0.7%

3.2%

Hydroxycapsaicin 50 g/mL

1.0%

6.8%

0.3%

83.7%

14.7%

Capsaicin 100 g/mL
0.9%

93.2%

HCT116 cells

1.3%

Solvent
control

Campto- 50
100
200
thecin
Capsaicin
(10 g/mL)
( g/mL)

50

100

200

Hydroxycapsaicin
( g/mL)

1.3%

4.5%

Capsaicin 200 g/mL
0.6%

1.2%

92.8%

5.3%

Hydroxycapsaicin 100 g/mL Hydroxycapsaicin 200 g/mL

0.7%

89.8%

1.8%

7.7%

1.2%

86.7%

1.9%

100

Number of apoptotic cells (%)

0.3%

91.3%

Propidium iodide PI

93.8%

3.5%

Annexin V-Alexa Fluor 488
Solvent control

0.9%

C

96.8%

0.6%

90

Late apoptosis
Early apoptosis

80
70
60
50
40
30
20
10
0

10.3%

Solvent Campto- 50
control thecin
(10 g/mL)

100

200

50

100

200

Hydroxycapsaicin
( g/mL)

Capsaicin
( g/mL)

Annexin V-Alexa Fluor 488
Camptothecin 7 g/mL

Solvent control
0.0%

97.0 %

0.1%

2.9%

Capsaicin 50 g/mL
0.1%

95.6 %

95.0%

80.6%

0.9%

4.3%

91.0%

0.1%

4.9%

HT29 cells

5.4%

100

11.7%

Capsaicin 100 g/mL

0.0%

Hydroxycapsaicin 50 g/mL

0.0%

2.3%

1.1%

7.0%

Capsaicin 200 g/mL
0.3%

88.5%

0.1%

11.5%

Hydroxycapsaicin 100 g/mL Hydroxycapsaicin 200 g/mL

0.3%

91.8%

0.1%

7.7%

0.4%

90.3%

1.1%

9.3%

Number of apoptic cells (%)

Propidium iodide PI

B

0.2%

Late apoptosis
Early apoptosis

90

Late apoptosis
Early apoptosis

90
80
70
60
50
40
30
20
10
0

Solvent Campto- 50
control thecin
(10 g/mL)

100
Capsaicin
( g/mL)

200

50

100

200

Hydroxycapsaicin
( g/mL)

Annexin V-Alexa Fluor 488

Figure 2. Apoptosis induction activities of capsaicin and hydroxycapsaicin against Vero cells and colon cancer cell lines. After 24 h of
treatment with the indicated concentrations, Vero cells (A), human colorectal carcinoma cell line (HCT116 cells) (B), and human colon
adenocarcinoma cell line (HT29 cells) (C) labeled with Alexa Fluor 488 annexin V and propidium iodide (PI) were analyzed by flow
cytometry to determine the percentage of cells displaying an increase in early and late apoptosis. Bar graph shows the summarized data
from 2 independent experiments performed in duplicate. Cells treated with DMSO (solvent control, 0.37%) and camptothecin (7–10 g/
mL) were used as negative and positive controls, respectively.
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in Vero cells (Figure 2A), indicating that hydroxycapsaicin
was much less toxic than capsaicin in a cell line lacking
capsaicin/vanilloid receptors (Creppy et al., 2000). These
results suggest that apoptosis induction by both capsaicin
and hydroxycapsaicin in cancer cells may be influenced by a
capsaicin/vanilloid receptor on the cell membrane. Although
apoptosis induction of hydroxycapsaicin and capsaicin
in HT29 cells was not significantly different (Figure 2C),
apoptosis induction of hydroxycapsaicin in HCT116 cells
was greater than that of capsaicin (Figure 2B).
3.5. Effect of hydroxycapsaicin on induction of cell-cycle
arrest in human colon cancer cell lines
In addition to apoptosis induction, cell-cycle arrest may
also underlie a growth inhibition effect of hydroxycapsaicin.
The possible effect of hydroxycapsaicin on cell-cycle
progression was investigated comparatively with capsaicin
in both Vero cells and colon cancer cell lines. As shown in
Figures 3A–3F, a significant dose-dependent alteration of
cell numbers in different cell-cycle phases was observed. In
both Vero cells and colon cancer cells, capsaicin treatments
for 24 h caused substantial cell death/apoptosis with the
dramatic increase of the sub-G0/G1 peak (Figures 3A, 3C,
and 3E), whereas hydroxycapsaicin induced lower levels
of cell death at high concentrations (Figures 3B, 3D, and
3F). In Vero cells, capsaicin treatments at 50 and 100 µg/
mL for 24 h induced an increase of cells in the S-phase of
the cell-cycle (Figure 3A). Interestingly, hydroxycapsaicin
treatment at the highest concentration (200 µg/mL) for 24
h induced both an elevation of cell death and cell-cycle
arrest at the S and G2/M phases in Vero cells (Figure
3B). In both HCT116 and HT29 cells, hydroxycapsaicin
treatment caused cell-cycle arrest at the S-phase of the cell
cycle (Figures 3D and 3F). In contrast, capsaicin treatment
caused no cell-cycle arrest (Figures 3C and 3E) in these
colon cancer cells.
4. Discussion
HDAC inhibition by HDAC inhibitors shows promising
effects for cancer therapy (Mark and Xu, 2009). Although
the link between HDAC inhibition and apoptosis
induction is not fully understood, treatments with
HDAC inhibitors usually cause a shift in the balance of
pro- and antiapoptotic genes toward apoptosis (Carew et
al., 2008). The cellular response to HDAC inhibition is
complicated and appears to involve both transcriptional
and nontranscriptional events. The substrates for HDAC
enzymes are not only the histone proteins but also more
than 50 nonhistone proteins, such as transcription
factors, DNA repair proteins, DNA-binding proteins,
chaperone proteins, and signal-transduction molecules
(Ocker, 2010). Inhibition of HDAC enzymes promotes
the acetylation of both histone and nonhistone proteins,
resulting in downregulation of prosurvival proteins such as

Bcl-2 and Bcl-1, which maintain integrity of mitochondria
(Rikiishi, 2011), and upregulation of proapoptotic proteins
such as Bim, Bak, and Bax, which initiate intrinsic cell
death pathways (Zhao et al., 2005; Zhang et al., 2006). In
addition, hyperacetylation has been shown to stabilize p53
and activate cell-cycle arrest in cancer cells (Xu, 2006).
However, the link between hydroxycapsaicin-induced
hyperacetylation and induction of cell-cycle arrest and
apoptosis in both HT29 and HCT116 cells (Figures 2 and
3) remains to be investigated. There are 11 family members
of zinc-dependent HDACs (Martinez-Iglesias et al., 2008;
Mark and Xu, 2009), which commonly have a narrow
pocket and zinc (Zn2+) ion in the catalytic site. The general
structural characteristics of TSA and SAHA that strongly
inhibit zinc-dependent HDAC isozymes include a zincbinding moiety, an opposite capping group, and a straightchain alkyl linker connecting the zinc-binding moiety and
the capping group (Finnin et al., 1999; Mark and Xu, 2009).
Based on its structural similarity with SAHA and TSA, we
hypothesized that hydroxycapsaicin may have a similar
orientation and binding mode as SAHA or TSA in the active
site of zinc-dependent HDACs. Here we demonstrated
that hydroxycapsaicin could inhibit HDAC activity both
in vitro and in human cells. However, hydroxycapsaicin
exhibited little effect on HDAC inhibition in a cellular
model (Figure 1) and its HDAC inhibitory activity did
not correspond well with the in vitro results (Table 1). The
minimal HDAC inhibition by hydroxycapsaicin in HeLa
cells may result from the existence of vanilloid receptor
(TRPV1) on the plasma membrane of this cell line (Ahn
et al., 2014), preventing some hydroxycapsaicin molecules
from entering the cells.
The HDAC inhibitory activity of hydroxycapsaicin
makes it more attractive in combination chemotherapy
because HDAC enzymes are different chemotherapeutic
drug targets than those of highly effective chemotherapeutic
drugs such as cisplatin, 5-fluorouracil, and doxorubicin.
For example, combination therapies using HDAC
inhibitors vorinostat and sodium butyrate with aurora
kinase inhibitors and doxorubicin, respectively, enhance
activity against cancer cells (Cheriyath et al., 2011; Kretzner
et al., 2011). Accordingly, further studies on specificity for
specific HDAC family members and HDAC inhibition in
more cancer cell lines of hydroxycapsaicin are of interest.
Hydroxycapsaicin was synthesized to provide a novel
HDAC inhibitor and to overcome capsaicin’s toxicity.
Here we demonstrated that a novel HDAC inhibitor,
hydroxycapsaicin, was about 2 times less toxic than
the prototype capsaicin in both colon cancer cell lines
and a cell line lacking capsaicin receptor (Table 2). Our
preliminary data revealed that hydroxycapsaicin inhibited
cell proliferation through induction of apoptosis (Figure 2)
and cell-cycle arrest (Figure 3). Capsaicin was more toxic to
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Figure 3. Induction of cell cycle arrest by capsaicin and hydroxycapsaicin in Vero cells and colon cancer cell lines. After 24 h of treatment
with the indicated concentrations, Vero cells (A, B), human colorectal carcinoma cell line (HCT116 cells) (C, D), and human colon
adenocarcinoma cell line (HT29 cells) (E, F) were stained with propidium iodide (PI) and analyzed by flow cytometry to determine
the cellular phase distribution. The graph shows the summarized data from 2 independent experiments performed in duplicate. Cells
treated with DMSO (0.37%) were used as a control. Asterisk indicates a significant difference (P < 0.05) compared with a control group.
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the cells lacking capsaicin receptors (Vero cells) than those
possessing capsaicin receptors (HT29 and HCT116 cells)
(Figure 2; Table 2), suggesting that capsaicin toxicity might
be affected by the capsaicin receptor. Capsaicin has been
shown to inhibit cell proliferation via inhibition of protein
synthesis (Creppy et al., 2000) and endoplasmic reticulum
stress-induced autophagy/apoptosis (Oh and Lim, 2009).
It is of interest to investigate whether hydroxycapsaicin
may exert the same mechanisms as capsaicin to inhibit cell
proliferation.
The aim of chemotherapy is to kill cancer cells by
inducing apoptosis. In this study, we identified apoptotic
cells by detecting the “eat-me” signal of apoptotic cells
(Ravichandran, 2010), an externalized phosphatidylserine,
using a combined annexin V/PI dual staining assay. Here
we demonstrated that the effect of hydroxycapsaicin on
apoptosis induction was greater than that of capsaicin in
HCT116 cells (p53 wild type), but not different in HT29
cells (p53 mutant) (Figure 2). This apparent finding
suggests that the presence of p53 may facilitate apoptosis
induction by hydroxycapsaicin. However, the involvement
of p53 in apoptosis induction by hydroxycapsaicin in
HCT116 cells remains to be clarified.
In addition to apoptosis induction, cell-cycle arrest
is also a mechanism to suppress cancer cell growth.
However, the induction of cell-cycle arrest by capsaicin
appeared to be specific to cell type and to play a limited
role in some cancer cells, including KB cells (Lin et al.,
2013). Consistently, in this study, cell-cycle arrest was not

observed upon capsaicin treatment in either HCT116 or
HT29 cells (Figures 3C and 3E), in which the suppression
of their growth may be more correlated with induction of
cell death/apoptosis. Interestingly, hydroxycapsaicin, with
HDAC inhibitory activity and less toxicity, suppressed
the growth of both colon cancer cell lines, at least in part,
via induction of cell-cycle arrest at the S-phase. However,
the molecular mechanisms underlying hydroxycapsaicininduced cell-cycle arrest at the S-phase in both colon
cancer cell lines are unknown and further investigation is
needed.
In conclusion, hydroxycapsaicin, a capsaicin-based
HDAC inhibitor, exhibited HDAC inhibitory effects both
in vitro and in cellular model. However, vanilloid receptors
may limit the effect of its HDAC inhibitory activity in a
cellular context. Exposure of both colon cancer cell lines
(HCT 116 and HT29 cells) to hydroxycapsaicin reduced
cell proliferation, induced apoptosis, and stimulated
cell-cycle arrest at the S-phase. These findings suggest
that hydroxycapsaicin possesses HDAC inhibitory and
anticancer activities and may be a potential anticancer drug.
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